Global Mobility Aids Market Forecast: Growth Drivers and Strategic Opportunities for B2B Buyers
The global mobility aids market is expanding steadily, and buyers who plan around the forecast can secure better pricing and supply terms. Analysts project the personal mobility devices segment to grow from $12.9 billion in 2025 to $20.1 billion by 2033, a compound annual growth rate (CAGR) of 5.8% (Grand View Research, 2025). The wider mobility aids category shows similar momentum, rising from $7.55 billion in 2022 to a projected $13.34 billion by 2030, a 7.4% CAGR (Research and Markets, 2022). For wholesalers, distributors, nursing homes, and home healthcare providers in North America, these figures signal rising end-user demand and new pressure on pricing, lead times, and supplier qualification. This guide covers the growth drivers, regional outlook, product segments, and procurement strategies that will shape the market through 2028.
Key Takeaways
- The mobility aids market is forecast to reach $13.34 billion by 2030 (Research and Markets, 2022), with personal mobility devices projected at $20.1 billion by 2033 (Grand View Research, 2025).
- Aging demographics are the primary demand engine: 2.1 billion people will be aged 60 or older by 2050, up from about 1 billion in 2020 (UN DESA, 2023).
- North America and Europe lead in revenue per unit; Asia-Pacific leads in unit volume.
- ISO 13485 certification is becoming a baseline requirement in hospital and home care RFPs.
- Buyers who lock in 12–24 month supply agreements reduce exposure to rising material costs and lengthening lead times.
What is driving the global mobility aids market forecast?
Three structural forces underpin the forecast: aging populations, rising chronic disease prevalence, and the post-pandemic shift toward home-based care.
Aging demographics. The world’s population aged 60 and older will double to 2.1 billion by 2050 (UN DESA, 2023). In the United States, more than 1 in 4 adults lives with some form of disability, including 13.9% with mobility limitations (CDC, 2026). Every additional year of life expectancy adds demand for walkers, rollators, wheelchairs, and bathroom safety equipment.
Chronic disease prevalence. An estimated 1.3 billion people — 16% of the global population — experience significant disability (WHO, 2023). Conditions such as osteoarthritis, diabetes, and stroke sequelae create sustained, non-seasonal demand for mobility products.
Home care shift. Payers and families increasingly prefer care at home over institutional settings. That shift moves equipment purchases from hospital procurement to home healthcare agencies, DME suppliers, and retail distributors — expanding the addressable market for B2B suppliers.
How do regional markets compare for B2B buyers?
Demand is not uniform across geographies, and each region rewards a different sourcing posture.
| Region | Market position (2025) | Primary growth driver | Buyer implication |
|---|---|---|---|
| North America | Largest revenue base; premium pricing | Aging population, Medicare/Medicaid reimbursement | Prioritize certified, documentation-ready suppliers |
| Europe | Mature; strong regulatory barrier | Aging demographics, CE/MDR compliance | Full technical files and EU labeling are decisive |
| Asia-Pacific | Fastest unit-volume growth | Rapid urbanization, expanding middle class | Cost-competitive sourcing; verify quality systems |
North America. The United States and Canada combine the broadest reimbursement coverage with the steepest demographic curve: 1 in 4 older adults reports a fall each year (CDC, 2026), feeding demand for bathroom safety and mobility products. Institutional buyers should expect to provide product documentation, ISO 13485 certificates, and liability-conscious packaging to end customers.
Europe. CE marking under the EU Medical Device Regulation (MDR) remains the dominant market barrier. Distributors increasingly require complete technical files from overseas manufacturers, which makes certified suppliers with EU-compliant labeling the lower-risk choice.
Asia-Pacific. Unit volumes climb fastest here as aging societies in Japan, South Korea, and China expand coverage. For North American buyers, the region matters mainly as a sourcing base — and risk depends on the factory’s quality system, not its location.
Which mobility aid product segments are growing fastest?
Four segments dominate B2B procurement volume:
- Walkers and rollators. The walking aids market was valued at $2.2 billion in 2021 and is growing at a 7.1% CAGR (Grand View Research, 2021). Lightweight rollators lead SKU growth. Compare models in our rollator walkers range.
- Wheelchairs. Manual and lightweight models drive institutional repeat orders, while bariatric configurations command premium pricing.
- Bathroom safety. Shower chairs, commodes, and grab bars ride the aging-in-place wave and post some of the fastest category growth — see our bathroom safety equipment market analysis.
- Canes and crutches. High-volume, low-unit-price items that anchor distributor catalogs and generate dependable reorder cycles.
How should B2B buyers adapt procurement strategy in 2026–2028?
A growing market rewards buyers who act early on three fronts.
1. Lock in supply early. Demand growth tightens factory capacity during peak seasons. Distributors who commit to forecast-based orders — rather than spot buying — secure better lead times and priority allocation.
2. Diversify sourcing. Relying on a single factory concentrates risk from tariffs, logistics disruptions, and raw material price swings. A dual-sourcing strategy with certified manufacturers reduces exposure without doubling inventory.
3. Make certification a filter, not a checkbox. ISO 13485 is the international standard for medical device quality management systems (ISO). Institutional RFPs increasingly treat certification as mandatory, so a certified partner shortens qualification cycles and reduces audit burden.
“Institutional buyers are no longer comparing prices alone. They compare quality systems, audit history, and the manufacturer’s ability to document compliance. In a market growing at 6–7% per year, a certified partner with stable lead times is worth a premium,” says Robert Lindqvist, Director of Procurement, NordicCare Health Supply Network.
What does the forecast mean for your next sourcing decision?
The data favors buyers who plan 12 to 24 months out. Confirm volume projections, evaluate supplier certification, and test small-batch orders before committing to annual contracts. Category managers at large DME chains report that supplier capacity, not price, is the binding constraint during Q3 peak demand — a pattern that repeats as the market grows (Grand View Research, 2025).
“The smartest buyers treat mobility aids as a strategic category, not a commodity. They consolidate SKUs, standardize on certified suppliers, and negotiate multi-year agreements with built-in escalation clauses,” adds Dr. Elena Marchetti, Senior Market Analyst, Global MedTech Insights.
JiNDA Health Care manufactures rollators, wheelchairs, canes, and bathroom safety equipment under an ISO 13485 quality system. Contact our B2B team for MOQ and lead-time details, or browse the walker and rollator range.
FAQ
1. How large is the global mobility aids market?
The mobility aids market was valued at $7.55 billion in 2022 and is forecast to reach $13.34 billion by 2030, a 7.4% CAGR (Research and Markets, 2022).
2. What is the projected growth rate for mobility aids?
Most analysts place the CAGR between 5.8% and 7.4%, depending on product scope and forecast window (Grand View Research, 2025; Research and Markets, 2022).
3. What is the best way to enter this market as a distributor?
Start with high-turnover categories — canes, rollators, and bathroom safety — then expand into wheelchairs as volume grows.
4. Which regions offer the best growth opportunity?
North America and Europe deliver the highest revenue per unit, while Asia-Pacific offers the fastest volume growth for cost-competitive sourcing.
5. Do I need ISO 13485-certified suppliers?
Yes, for most institutional sales. Hospitals and home healthcare agencies increasingly require ISO 13485 certification in RFPs and vendor qualification.
6. How should I negotiate lead times with manufacturers?
Commit to 6–12 month forecast-based orders and request priority allocation in writing; spot orders face the longest delays during peak demand.
Written by JiNDA Health Care | Reviewed by Dr. James Palmer, PT, DPT, ATP — Clinical Education Advisor
Last updated: August 2026